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Summary 
Microbial functions in the host physiology are a result of the microbiota-host co-
evolution. We show that cold exposure leads to marked shift of the microbiota 
composition, referred to as cold microbiota. Transplantation of the cold microbiota to 
germ-free mice is sufficient to increase insulin sensitivity of the host, and enable 
tolerance to cold partly by promoting the white fat browning, leading to increased energy 
expenditure and fat loss. During prolonged cold however, the body weight loss is 
attenuated, caused by adaptive mechanisms maximising caloric uptake and increasing 
intestinal, villi and microvilli lengths. This increased absorptive surface is transferable 
with the cold microbiota leading to altered intestinal gene expression promoting tissue 
remodelling and suppression of apoptosis - effect diminished by co-transplanting the 
most cold-downregulated strain Akkermansia muciniphila during the cold microbiota 
transfer. Our results demonstrate the microbiota as a key factor orchestrating the overall 
energy homeostasis during increased demand.  
 
Introduction 
Food intake, energy expenditure (EE) and body adiposity are homeostatically regulated, 
and malfunctions of this balance can cause obesity (Murphy and Bloom, 2006) (Farooqi 
and O'Rahilly, 2005). Mammalian white adipose tissue (WAT) is an important regulator 
of the whole body homeostasis that stores energy in form of triglycerides (TGs). The 
brown adipose tissue (BAT) catabolises lipids to produce heat, function mediated by the 
tissue-specific uncoupling protein 1 (Ucp1) abundantly present in the BAT mitochondria. 
BAT differentiation can be induced by prolonged cold exposure and beta-adrenergic 
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stimulation which leads to elevated intracellular cyclic AMP (Cannon and Nedergaard, 
2004) (Young et al., 1984). The BAT is present at distinct anatomical sites, including the 
interscapular, perirenal and axillary depots. Brown fat cells also emerge in subcutaneous 
WAT (SAT) (known as “beige” cells) in response to cold or exercise (Cousin et al., 
1992) (Guerra et al., 2001), a process referred to as WAT browning. Loss of BAT 
function is linked to obesity and metabolic diseases (Lowell et al., 1993). Promotion of 
increased BAT development on the other hand, increases EE without causing dysfunction 
in other tissues and is associated with a lean and healthy phenotype (Ghorbani et al., 
1997; Guerra et al., 1998; Kopecky et al., 1995), suggesting the manipulation of the fat 
stores as an important therapeutic objective. 
 
The gastrointestinal tract is the body's largest endocrine organ that releases a number of 
regulatory peptide hormones that influence many physiological processes (Badman and 
Flier, 2005). The intestinal epithelium undergoes rapid self-renewal fueled by multipotent 
Lgr5-expressing stem cells located in the crypts of Lieberkuhn and is terminated by 
apoptosis/exfoliation of terminally differentiated cells at the tips of small intestinal villi 
(Sato et al., 2009). At the apical surface, the epithelial cells have microvilli that further 
substantially increase the absorptive area and mediate the secretory functions. The 
intestinal microbiota co-develops with the host, and its composition is influenced by 
several physiological changes (Koren et al., 2012; Liou et al., 2013; Ridaura et al., 2013). 
The colonization starts immediately after birth and is initially defined by the type of 
delivery and early feeding. After one year of age, the intestinal microbiota is already 
shaped and stabilized, but continues to be influenced by environmental factors including 
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diet (Sekirov et al., 2010). A wide range of pathologies have been associated with 
alterations of the gut microbial composition (e.g.: asthma, arthritis, autism or obesity) 
(Sommer and Backhed, 2013). The intestinal microbiota can also influence the whole-
body metabolism by affecting energy balance (Backhed et al., 2004) (Chou et al., 2008) 
(Turnbaugh et al., 2006) (Koren et al., 2012) (Ridaura et al., 2013). The mechanisms and 
the nature of the phenotypic and morphological changes that regulate the energy 
homeostasis of the new host following microbiota transplantation remain poorly 
understood.  Here we show that the microbiota remodelling is an important contributor of 
the beige fat induction during cold, and a key factor that promotes energy uptake by 
increasing the intestinal absorptive area, thus orchestrating the overall energy 
homeostasis during increased energy demand. 
 
Results 
Cold Exposure Changes the Gut Microbiota Composition. Short-term cold exposure for 
up to ten days leads to increased EE relative to the energy uptake, and suppresses BW 
and white fat mass gain (Figure S1A–F) (Wu et al., 2012; Wu et al., 2013). To investigate 
the importance of the acutely consumed food and caloric harvest during cold exposure, 
we restricted the food access during the initial 8 hours (hr) of cold exposure, or depleted 
the intestinal microbiota using broad range antibiotics (Abx) administered in the drinking 
water. The higher fecal caloric content after complete microbiota depletion was 
confirmed using bomb calorimetry (Figure S1G), and was consistent with previous 
reports (El Kaoutari et al., 2013), suggesting lower energy harvest from the food. 
Restricting the food access during acute cold exposure led to decreased body temperature 
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(Figure 1A, B) compared to ad libitum fed control mice, and to marked drop in the blood 
glucose and BW at cold (Figure S1H–J). The decreased tolerance to cold and lowered 
blood glucose levels were also evident in the Abx mice and the changes were relatively 
stable during short and long-term microbiota depletion up to four weeks of treatment 
(Figure 1C–E, S1K–R), despite the stable food intake and slightly increased water 
consumption (Figure S1S,T). These data suggest that the energy harvest during acute cold 
contributes to maintaining the body temperature, and that the intestinal microbiota is 
supporting this process.  
 
We observed that over time, the overall fat loss was attenuated despite the stable food 
intake and EE (Figure S1A–F), suggesting compensatory mechanisms that enable 
increased caloric harvest from the consumed food. To investigate whether this prolonged 
cold exposure causes changes in the intestinal microbiota, we collected feces at days 0, 
11 and 31 and cecum post–mortem of cold-exposed mice and RT controls. Profiling of 
the microbiota composition by 16S rRNA gene sequencing, followed by principal 
coordinates analysis (PCoA) based on weighted UniFrac distance showed major 
alterations of the microbiota content both in cecum, and feces samples of cold exposed 
animals (Figure S2A, B, Figure 1F). As expected, Firmicutes was the richest phylum in 
all samples (on average 69.10%) (Figure 1I, J). Bacteroidetes was the most abundant 
phylum (on average 63.50%) in all samples except the cold exposed day 31 samples 
(Figure S2C–E). We observed differences in operational taxonomic units (OTUs) 
abundance at phylum-level in Bacteroidetes, Firmicutes, Verrucomicrobia, 
Deferribacteres, Cyanobacteria and Actinobacteria; and differences in OTU numbers at 
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phylum-level in all the above plus Deferribacteres based on factor summary barchart. 
Individual species, or family based hierarchical clustering using the average-neighbor 
method confirmed the major shift of the microbiota composition, and showed clustering 
of the samples from the cold exposed versus the room temperature (RT) groups in both 
feces and cecum samples (Figure 1G, S2D,F, S3A,B). Comparison of phylum level 
proportional abundance in feces showed shifts in proportions (Figure 1H, S2C), 
especially in the ratio Firmicutes/Bacteroidetes where Firmicutes abundance (from 18.6% 
in RT up to 60.5% under cold) increased over Bacteroidetes (from 72.6% in RT to 35.2% 
under cold). The Verrucomicrobia phylum was almost absent from both feces and cecum 
after the cold exposure (from 12.5% for the RT to 0.003% for the cold in cecum) (Figure 
1H, S2C, E). Interestingly, similar shifts, although less pronounced, are associated with 
genetic and high fat diet induced obesity (Turnbaugh et al., 2006). The shifts in phylum 
abundance correlated with the richness of the species present in them. Firmicutes phylum 
increased its richness in feces up to 78.1% under cold exposure (compared to 65% in RT) 
and Bacteroidetes decreased it to 18.8% (compared to 29.7% in RT) (Figure 1I, J), 
without changing the overall bacterial diversity based on the Shannon diversity index 
(Figure S3C, D). From the 3864 OTUs detected, using Welch t-test done across the two 
groups of samples using the abundance metrics, 252 OTUs (within 44 families) were 
significantly different (p < 0.05). Of the selected families, there were mixed responses in 
Firmicutes, Proteobacteria and Bacteroidetes, however those within Actinobacteria, 
Verrucomicrobia and Tenericutes were less abundant in the cold samples, while RT 
samples were less abundant in Deferribacteres (Figure 1K). When looking at the most 
significantly changed OTUs using analysis of variance, Akkermansia muciniphila and 
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S24-7 family were among the top 9 most shifted bacteria (Figure S3G, H). 
Verrucomicrobia phylum was represented by 8 different OTUs, all part of the same 
species: Akkermansia muciniphila, which we found highly decreased with cold exposure 
(Figure S3E, F). The changes in the major bacterial phyla were confirmed by qPCR in the 
sequenced, as well as in independent sets of SPF and conventional animals (Figure S3I–
L). Together these results demonstrate a major shift in lower gut microbiota in response 
to cold exposure.  
 
Cold Microbiota Transplantation Increases Insulin Sensitivity. To investigate the 
importance of the microbiota changes during cold, we transplanted the microbiota from 
30 days cold-exposed, or control RT mice to GF mice by co-habitation, and again 
confirmed the shifts in the donors and the recipient mice (Figure S3K, L). As expected, 
cold exposure of donor mice led to a marked increase in the insulin sensitivity (Figure 
2A). Strikingly, cold microbiota transplanted mice also showed increased sensitivity to 
insulin (Figure 2B), suggesting that cold microbiota alone is sufficient to transfer part of 
this phenotype. The increased insulin sensitivity was further investigated using 
hyperinsulinemic-euglycemic clamp in awake and unrestrained mice. Cold mice showed 
a marked increase in the glucose infusion rates (GIR) needed to maintain the clamped 
glucose levels, and an increase in the stimulated glucose disappearance (Rd) levels 
(Figure 2C, D, S4A).  To investigate the peripheral glucose uptake, we co-administered 
2-[14C]deoxyglucose (2[14C]DG) during the clamp. While no changes were observed in 
the glucose uptake from interscapular BAT (iBAT), brain, soleus or quadriceps muscle, 
there was a large increase in the uptake from inguinal subcutaneous and perigonadal 
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(epididymal in males) visceral depots of the WAT (ingSAT and pgVAT, respectively) 
(Figure 2E). These observations were further corroborated in glucose stimulated and 
basal conditions (Figure 2F, G), which in addition showed increased glucose uptake in 
iBAT. Interestingly, the cold microbiota transferred the fat specific glucose disposal 
phenotype to the transplanted mice as measured by 2[14C]DG uptake (Figure 2H), and by 
positron emission tomography-computed tomography (microPET-CT). Specifically, both 
ingSAT and pgVAT, but not quadriceps muscle, showed increased 
[18F]fluorodeoxyglucose ([18F]FDG) uptake in the cold transplanted mice (Figure 2I–K), 
and had decreased ingSAT and pgVAT volumes and weights (Figure 3A–F, S4B). 
Hounsfield unit (HU) analysis of the microCT scans revealed that cold microbiota 
transplanted mice had higher ingSAT and pgVAT density compared to the controls 
(Figure 3G, H). Together, these data suggest that the cold microbiota contributes to the 
increased insulin sensitivity observed during cold exposure, and leads to decreased total 
fat coupled with increased fat density.  
 
Cold Microbiota Promotes Browning, Energy Expenditure and Cold Tolerance. To 
investigate whether the higher density and the decreased fat amount (Figure 3A–H) are 
originating from the differences in the adipocyte volume, we measured the adipocyte size 
distribution using high content imaging. Cold transplanted mice had increased number of 
small, and decreased number of large adipocytes in the ingSAT and pgVAT depots 
(Figure 3I–L). The adipose depots excised from the cold transplanted animals were 
darker in appearance. All these phenotypic events are characteristic features of mature 
beige adipocytes. Therefore, we investigated whether cold microbiota could affect the 
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browning of the white fat depots, and found that cold transplanted mice had marked 
increase in the brown fat specific markers in the ingSAT, and surprisingly, also in the 
pgVAT depots (Figure 3M, O). The increased browning of ingSAT was consistent with 
the increased Ucp1-positive cells in the cold transplanted mice (Figure 3N). There was a 
tendency bordering significance towards increased brown fat marker expression in the 
interscapular BAT (iBAT) depots of the cold transplanted mice, albeit at smaller scale 
compared to ingSAT and pgVAT (Figure 3P). Together, these data suggest that cold 
microbiota alone can be sufficient to induce beige/brown fat formation primarily in the 
ingSAT and pgVAT, and to a smaller magnitude in the iBAT depots. The increased 
browning was consistent with the enhanced resting EE (REE) of the cold transplanted 
mice (Figure 3Q), suggesting increased energy dissipation. To further investigate it’s 
functional relevance, we exposed the cold transplanted mice to acute cold, and monitored 
the internal body temperature, as well as ventrally or dorsally, indicative of the 
temperature emitted from ingSAT, or iBAT depots. The rectal temperature measurements 
showed that the RT transplanted mice had decreased body temperature following 4 hr of 
cold exposure, but only a mild temperature drop was detected in the cold transplanted 
mice (Figure 4A, B). Accordingly, the infrared imaging and quantification of the 
different regions (Figure 4C) demonstrated that cold microbiota transplanted mice are 
fully resistant to cold stress as shown by the eye temperature measurements, 
representative of the internal body temperature (Figure 4D, G). Analysis of the dorsal and 
ventral infrared images showed that the inguinal and the interscapular region contribute 
to the overall tolerance to cold. Specifically, while the differences in dorsal temperatures 
were transient between the groups (Figure 4E, H), the maximal ventral heat differences 
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remained constant also after 12 hr of cold exposure (Figure 4F, I). These data suggest a 
mechanistic explanation for the increased insulin sensitivity, and demonstrate that the 
cold microbiota alone is sufficient to induce tolerance to cold, increased EE and lower fat 
content, and that this effect is partially mediated by the browning of the white fat depots.  
  
Cold Exposed, and Cold Microbiota Transplanted Mice Have Increased Intestinal 
Absorptive Surface. Next, we monitored short-chain fatty acids (SCFAs), volatile 
compounds and organic acids associated with gut flora activity using mass spectrometry 
(Table S1 and S2). In lipid cecal extracts butyrate, the primary energy source in colon 
and the most abundant SCFA (Ferreyra et al., 2014), was markedly decreased in 
antibiotic treated mice and, accordingly, increased upon gut flora transplantation (Table 
S2). Similarly, succinate, a frequent product of primary fermenters that is utilized by 
butyrogenic bacteria (Wichmann et al., 2013), was decreased in absence of gut flora. We 
observed increase of propionate, butyrate, lactate and succinate in cold transplanted mice 
(Table S2). These results could indicate increased fermentation activity of cold over RT 
microbiota, associated with increased energy harvest.  
 
As mentioned, during long-term cold exposure and after the initial weight loss, the BW 
stabilizes despite the constantly increased EE rates and heat production, suggesting 
increased nutrient absorption from the relatively stable food intake. Oral glucose 
tolerance tests (OGTT) in cold exposed mice with or without microbiota depletion 
showed an elevated glucose peak following glucose gavage compared to RT controls 
(Figure 5A, S4C–G) after 15 min, but also faster clearance, consistent with the increased 
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insulin sensitivity (Figure S4H). Interestingly, no differences were observed in the initial 
glucose peak when glucose was administered intraperitoneally (Figure S4I). This 
suggests that orally administered glucose is rapidly taken up in cold exposed and in 
microbiota depleted mice. The rapid glucose uptake was observed also in the cold 
transplanted mice, which showed increased glucose peaks 7.5 and 15 min after glucose 
gavage (Figure 5B), and no changes in the insulin release compared to the RT 
transplanted (Figure S4J). This was consistent with increased triglyceride uptake and 
non-esterified fatty acid levels in the cold transplanted mice (Figure 5C, D), suggesting 
increased total energy harvest levels following oral gavage in the cold transplanted mice. 
To confirm that cold exposure leads to increase in the calorie uptake, we measured the 
fecal caloric content using bomb calorimetry and calculated the total energy uptake. Cold 
exposed mice showed increased caloric uptake, and this was phenocopied in the cold 
transplanted mice (Figure 5E, F). These data suggested increased intestinal absorptive 
capacity following cold exposure, which is transferable by the microbiota transplantation. 
We therefore looked at the intestine in more detail, and observed a marked increase in the 
lengths and weights of the small intestine in the cold exposed mice as early as 9 days 
after initiation of cold exposure (Figure S5A–C), persisting up to 30 days of cold (Figure 
5G, S5D). Microbiota depletion also led to increased intestinal length and weight, 
however, the changes in this case were more pronounced after 30 days of Abx treatment, 
and were consistent with the increased intestinal length in the GF mice (Figure 5G–I, 
S5D). Cold exposure of the Abx and GF mice led to dramatic increases of their intestinal 
lengths amounting to almost 35%, and weights of over 150% compared to the RT 
controls, demonstrating remarkable plasticity of the small intestinal absorptive tissue in 
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response to the increased energy demand (Figure 5G–I, S5D, E). The rest of the tissues, 
such as the colon, stomach, iBAT, or quadriceps muscle did not show obvious 
morphological changes (Figure S5D–G), except the decreased WAT levels described 
above. The increased intestinal length was still present 3 weeks after the end of the cold 
exposure in the donor mice that were used to transplant the GF mice (Figure 5J, H). 
Strikingly, cold microbiota transplanted mice also showed a marked increase in the 
intestinal lengths and weights compared to the RT transplanted controls, suggesting that 
the microbiota contributed to this phenotype (Figure 5L, M, S5K). To further investigate 
the changes in the intestinal morphology, we measured the intestinal perimeter and villus 
length, and found that both were increased in the cold mice, and were further enlarged in 
the cold exposed Abx mice (Figure 5N–P). This characteristic however was not 
transferred by the microbiota transplantation, consistent with the proportional increase in 
the intestinal lengths and weights in the transplanted mice, compared to the donors in 
which the ratio weight vs. length increased by 1.8 fold.  
 
To investigate the intestinal morphological changes, we quantified the relative 
contribution of the different cell types composing it - stem cells and Paneth cells in the 
bottom of the crypt and enterocytes, goblet cells and enteroendocrine cells along the villi. 
In our models, the number of the enteroendocrine cells was increased in the cold exposed, 
and cold exposed Abx treated mice, but also in the cold transplanted mice, proportional to 
the overall increase in the average cell number (Figure S6A–E). There was an antibiotics-
dependent effect in the number of goblet cells, which were increased upon microbiota 
depletion, but no changes were observed in the cold transplanted mice (Figure S6F–H, L, 
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M). Olfm4 is a highly specific and robust marker for Lgr5 positive stem cells. 
Quantification of the Olfm4+ cells showed increment only in the intestine of cold 
exposed Abx treated mice, consistent with their most pronouncedly enlarged intestine 
(Figure S6I–K). These data suggest that cold exposure leads to a number of changes in 
the intestinal composition, which in the case of the enteroendocrine cells are in part 
transferable by cold microbiota transplantation. 
 
Microvilli form the brush border on the apical epithelial surface of the small intestine, 
and a single enterocyte can have as many as 1000 microvilli, each one formed by cross-
linked actin bundles. They increase the surface area of the absorptive cell approximately 
25-fold. Using quantitative electron microscopy (EM), we found that the microvilli 
length is substantially increased in the cold exposed, as well as in microbiota depleted 
mice (Figure 6A–C), thus further largely increasing the intestinal surface area. Strikingly, 
these differences were also transferred in the cold microbiota transplanted mice, which 
showed increased microvilli lengths (Figure 6D–F). Together, these results demonstrate 
that during increased energy demand, specifically cold exposure, there is a dramatic 
increase in the intestinal absorptive surface area due to the increased intestinal, villi and 
microvilli lengths, and that cold microbiota transfer alone can be sufficient to induce 
these changes.  
 
Reduced apoptosis underlines the increased intestinal surface. To uncover the 
mechanisms of the microbiota-epithelium crosstalk responsible for the observed gut 
phenotype, we deep sequenced the transcriptome from proximal jejunum of RT, 
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RT+Abx, Cold and Cold+Abx mice. The expression profiles markedly differed between 
the groups (Figure 6G), and unbiased pathway enrichment analysis revealed changes in 
pathways involved in cytoskeletal remodeling, tissue growth, Wnt signaling, apoptosis 
and immune response common for mice with increased intestinal surface (Cold, RT+Abx 
and Cold+Abx), when compared to RT mice (Figure 6H, I, S6N). Anti-microbial 
response and TNF signaling, which promote apoptosis and cell shedding, and are 
activated by bacteria through NF-κB and TLR pathways (Hausmann, 2010; Spehlmann 
and Eckmann, 2009), were strongly suppressed in all microbiota depleted mice (Figure 
S6N). Indeed, apoptosis and anti-apoptotic interleukin-15 signaling (Obermeier et al., 
2006), were among the top regulated pathways in the mice with increased intestinal 
surface (Figure 6H, I, S6N). Using the TUNEL assay we observed that compared to the 
RT mice, the apoptosis was markedly reduced in the villi of all other groups (Figure 6J). 
This phenotype was transferred in the cold transplanted animals, which retained the anti-
apoptotic phenotype of the GF and Abx mice (Figure 6K–O). Conversely, RT 
transplanted mice acquired increased apoptosis, exhibited reduction of the anti-apoptotic 
Il15, Bcl2l1 (coding isoform Bcl2-XL) and Mcl1 expression (Pelletier et al., 2002), and 
showed increased caspase 3 activation (Figure 6M–O). Concomitantly, the mice with 
increased intestinal surface had augmented vascularization and tissue remodeling gene 
expression, and showed marked increase in the main apical (Sglt1, gene Slc5a1) and 
basolateral (Glut2, Slc2a2) glucose transporters (Figure 6I, M). Together, these data 
suggest a mechanistic explanation of the increased intestinal surface area and glucose 
permeability, which can be transferred by the cold microbiota transplantation.  
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Cold Microbiota Increases Intestinal Absorption in Akkermansia muciniphila-Sensitive 
Manner. To finally demonstrate that the increased intestinal surface corresponds to 
enhanced absorptive capacity of the intestine, we did ex vivo experiments in isolated 
segments from the middle to proximal jejunum of the microbiota transplanted mice. 
Mucosal to serosal D[1-14C] Glucose (D[14C]G) apparent diffusion coefficient was higher 
in cold transplanted mice (Figure 7A), suggesting increased intestinal glucose absorption. 
This was consistent with the increased D[14C]G present in intestinal tissue after one hour 
of transport, and lower residual D[14C]G levels in the lumen (Figure 7B, C). Cold 
microbiota mice also had prolonged intestinal transit time, proportional to the increase in 
the intestinal length of the corresponding animals (Figure 7D). Since the increased 
intestinal surface area was also present in the microbiota depleted mice, we assumed that 
absence of certain bacterial strains, rather than increased abundance could be responsible 
for the observed intestinal phenotype following the cold microbiota transplantation. 
Akkermansia muciniphila (A. muciniphila) is a Gram-negative bacterium that commonly 
constitutes 3–5% of the gut microbial community. A. muciniphila within the mucus layer 
is implicated in the control of host mucus turnover (Belzer and de Vos, 2012), which 
improves gut barrier function, and is linked to obesity (Everard et al., 2013). Since A. 
muciniphila is the most abundant species of the Verrucomicrobia, the most negatively 
affected phylum in response to cold exposure, we investigated whether this strain alone 
could revert part of the transplanted phenotype. Co-transplantation of A. muciniphila 
fully prevented the cold microbiota transferable increase of the intestinal glucose 
absorption (Figure 7A–C), and decreased the intestinal transit time (Figure 7D). 
Moreover, the increased intestinal length caused by cold microbiota transplantation was 
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fully reverted in the cold microbiota + A. muciniphila transplanted animals (Figure 7E, 
S7A). These results were consistent with the OGTT, which showed a limited increase in 
the glucose peak 15 min after the gavage (Figure 7F), and no differences in the insulin 
levels between the groups (Figure S7B). Neither differences were observed in the 
tolerance to insulin and cold, nor in the expression of the beige fat markers (Figure S7C–
J), together suggesting that A. muciniphila does not negatively affect the browning or the 
sensitivity to insulin. Interestingly, A. muciniphila colonization reverted the changes in 
the Bacteroidetes/Firmicutes ratio in the cold transplanted mice (Figure S7K, L). 
Therefore, we investigated the importance of the rest of the bacterial consortium by 
mono-colonizing GF mice with A. muciniphila and observed no differences in the 
intestinal length and duodenum perimeter, while there was a small decrease of the 
microvilli length bordering significance (Figure S7M–P), suggesting that A. muciniphila 
is necessary, but not sufficient to revert the intestinal lengthening. In contrast, daily 
gavage of A. muciniphila to cold exposed mice decreased their BW and fat mass gain, 
and shortened their intestine and microvilli already after 7 days of cold exposure. The 
Bacteroidetes/Firmicutes abundance was not yet affected by the cold exposure at this 
time interval, showing that changes in their ratio is not a prerequisite for the intestinal 
remodeling, and that change in A. muciniphila precedes the remodeling of these major 
phyla (Figure 7G–J, S7Q–T). A. muciniphila re-colonization during the cold exposure 
decreased the OGTT peak, and prevented the cold induced increase in the intestinal 
absorptive capacity (Figure 7K–M, S7U). Accordingly, re-colonizing A. muciniphila 
reverted the cold induced decrease in the apoptosis levels, and reduced the expression of 
the key tissue remodeling, anti-apoptotic and glucose uptake genes during cold (Figure 
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7N–Q). Combined, these results underscore that the cold exposure-induced decrease of A. 
muciniphila enables increasing the intestinal absorptive surface by altering several key 
regulatory pathways, and that co-transfer of this strain together with the cold microbiota, 
or during the cold exposure is sufficient to prevent the adaptive increase in the intestinal 
absorptive functions which maximize the caloric uptake during cold.  
 
Discussion 
During evolution, mammals developed a number of adaptive responses to energy 
scarcity. Microbial diversity of the human gut is the result of co-evolution between 
microbial communities and their hosts. We assumed that this co-evolution favoured 
maximising uptake of calories from the consumed food during periods of increased 
energy demand, such as cold exposure. Indeed, cold exposure led to dramatic changes of 
the microbiota composition, increasing Firmicutes vs. Bacteroidetes ratios, and almost 
completely depleting the Verrucomicrobia phylum. We found that these changes 
favoured enhanced energy extraction during cold. Interestingly, in part this is rendered 
possible by an adaptive mechanism of the host that increases the overall intestinal 
absorptive surface, due to a marked elongation of the total intestinal, villi and microvilli 
lengths. When transplanted to GF recipient mice, the cold microbiota alone was sufficient 
to promote this increased intestinal absorptive surface area by lengthening the gut and the 
epithelial microvilli. Similar changes in the gut morphology were observed in microbiota 
depleted mice, which is also a condition of negative energy balance, suggesting that the 
increase in the intestinal absorptive surface is a general adaptive mechanism promoting 
caloric uptake when food is available.  
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In absence of microbiota, epithelial survival was promoted by removal of pro-apoptosis 
signals, up-regulation of growth factor cascades and increase in glucose transport. 
Colonization by different gut consortia interfered with these changes to different extents, 
either keeping most of them (cold microbiota) or restoring them to normal levels (RT or 
cold+A.muciniphila colonization). Cold exposure of the microbiota depleted mice 
however, further increased the intestinal length, suggesting that additional factors also 
contribute to this process. The observed increased intestinal absorptive capacity in 
absence of A. muciniphila could give additional explanation to its function in obesity, 
where absence of this bacterium enables increased uptake in surrounding of excess 
energy despite the constant intestinal length. This is consistent with our ex vivo data that 
show decreased glucose permeability in presence of A. muciniphila in isolated equal 
(2cm long) jejunal segments, and suggests that absence of this bacterium is necessary, but 
may not be sufficient to increase the intestinal length. Here we demonstrate that also in 
conditions of negative energy balance and lean and healthy phenotype, A. muciniphila 
absence enables increased caloric uptake. All this suggest that this bacterium may act as 
an energy sensor that is abundant during caloric deficiency, and is low when the energy is 
in excess, as a co-evolutionary mechanism enabling the energy uptake when available. 
Indeed, A.muciniphila is elevated in undernourished mice (Preidis et al., 2015), and in 
caloric restricted humans (Dao et al., 2015), both typical examples of energy scarcity; 
while it is absent during cold where food intake is strongly increased. Maintaining the 
increased gut length and absorptive surface is energy requiring. To ensure that the 
intestinal lengthening pays off, this process would need to depend on whether the energy 
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needed to maintain the increased intestinal surface is justified in promoting overall 
increase in the energy balance, which is not the case in conditions of low food 
abundance. Seen in this context, A. muciniphila is a unique example of host microbial 
mutualism regulating the energy homeostasis and enabling positive energy balance.  
 
In addition, our data demonstrate that the cold microbiota alone is sufficient to induce 
tolerance to cold, increased EE as well as lower fat content, and that this effect is at least 
in part mediated by browning of the white fat depots. This provides mechanistic 
explanation for the increased insulin sensitivity following cold microbiota 
transplantation, since increased browning protects against obesity and insulin resistance 
(Ghorbani et al., 1997; Guerra et al., 1998; Kopecky et al., 1995). A. muciniphila on the 
other hand could not explain the browning following microbiota transplantation, 
suggesting that additional changes in the intestinal microbiota are mediating this. Thus, 
discriminating and narrowing down the exact bacterial species affecting this would be an 
interesting area of future study. Fecal microbiota transplantation was reported almost 50 
years ago (Eiseman et al., 1958), and has re-gained interest as a treatment option for 
several pathologies (Ley et al., 2006) (Kelly, 2013) (Khoruts, 2014). In the context of the 
increased obesity prevalence and energy unbalance, our study showing microbiota 
changes that promote weight loss and energy dissipation, imply microbiota as a key 
player mediating the tight control of the energy homeostasis with large therapeutic 
potential.   
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Figure Legends 
Figure 1. Cold Exposure Changes the Gut Microbiota Composition 
(A) Rectal body temperature (BT) of food restricted, or ad libitum fed C57Bl6J mice 
after 4 and 8 hours (hr) of cold exposure (n=8 per group). 
(B) Change in BT compared to initial as in (A). 
(C) Rectal BT after 3 hr of cold exposure of male mice treated or not with antibiotics 
(n=8 per group). 
(D) Rectal BT after 4 hr and 24 hr of cold exposure, in antibiotics treated, or control 
female mice (n=6 per group).  
(E) Change in BT compared to initial as in D.  
(F) Principal coordinates analysis (PCoA) based on Weighted UniFrac analysis of OTUs. 
Each symbol represents a single sample of feces after 31 days of cold exposed (n=8) or 
RT controls (n=6 per group).  
(G) Hierarchical clustering diagram using the average-neighbor (HC-AN) method 
comparing feces of 31 days cold exposed mice (n=8) and their RT controls (n=6). 
Associated heat map shows the relative abundance of representative OTUs selected for p 
< 0.05, obtained with a Welch t-test comparison of the two groups, and then grouped into 
families. One representative OTU with the greatest difference between the two group 
means from each family is selected for inclusion in the heat map diagram. OTUs is 
shown as: Phylum, Class, Order, Family, Genus, and Species. R: RT; C: Cold exposed. 
(H) Comparison of phylum-level proportional abundance of cecum and feces of up to 31 
days cold exposed or RT control mice  
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(I, J) Richness represented as the proportions of OTUs classified at the phylum rank. in 
(I) feces, or (J) cecum. In (H), (I) and (J) n=5+6 (cecum), or 6+8 (feces). 
(K) Heatmap tree comparing selected OTUs abundance from feces of RT controls (n=6, 
inner rings) and 31 days cold exposed mice (n=8, outer rings) and their phylogenic 
relationships. The OTUs representative of differentially abundant families are selected as 
described in panel H.  
See also Figure S1, S2, S3. 
 
Figure 2. Cold Microbiota Transplantation Increases Insulin Sensitivity and WAT 
Glucose Uptake 
(A, B) Intraperitoneal insulin tolerance test (ITT) in RT and 25 days cold-exposed mice 
(A), or RT and cold microbiota transplanted mice (B) relative to initial blood glucose, 
(n=8 per group).  
(C-E) Euglycemic-hyperinsulinemic clamp of awake mice as in (A). Rate of 
disappearance of 3H-D-glucose (C). GIR time course during the hyperinsulinemic clamp 
(D). 2[14C]DG uptake in various tissues (E) (n=6+6).  
(F) 2[14C]DG tracer uptake in tissues 45min after IP tracer and glucose (2g/kg BW) 
administration in mice as in (A) (n=6 per group).  
(G, H) 2[14C]DG uptake in tissues 30 min after administration under basal conditions in 
anesthetized RT (n=9) and cold (n=10) (G); or RT and cold transplanted mice (n=3) (H). 
(I, J, L) Positron emission tomography-computer tomography (microPET-CT) 
measurement of [18F]FDG uptake in ingSAT (I), pgVAT (J), or quadriceps muscle (L) in 
basal conditions of RT and cold  transplanted mice as in (B). (n=6 per group).  
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(K) Transversal [18F]FDG PET-CT images of ingSAT and pgVAT of mice as in (I, J).  
See also Figure S4. 
 
Figure 3. Cold Microbiota Promotes Browning of WAT 
(A) 3D reconstitution of the ingSAT and pgVAT of cold and RT transplanted mice 21 
days after transplantation using the CT scans. Bar: 5mm. 
(B) Weight of fat pads of cold or RT transplanted mice after 5.5 weeks (n=6 per group).  
(C–H) IngSAT, or pgVAT volumes (C, E); or densities (G, H) of mice as in (A). Change 
in each fat pad volume (D, F) (n=12 per group, except (E, F) where n=6 per group) of 
same mice scanned at day 3, and day 21 after transplantation. 
(I, J) Cell size profiling of adipocytes from ingSAT (I), or pgVAT (J) of RT or cold 
transplanted mice 21 days after transplantation. The values show % from the total number 
of analyzed cells. Bars show mean of the pooled corresponding fractions from each 
animal ± sem (n=6 for each panel).  
(K, L) H&E staining on paraffin sections from ingSAT (K), or pgVAT (L) of RT or cold 
transplanted mice. 
(M, O, P) Relative mRNA expression in ingSAT (M), pgVAT (O), or iBAT (P) of RT or 
cold transplanted mice (n=6 per group), quantified by real-time PCR and normalized to 
the house keeping beta-2-microglobulin (B2M). 
(N) Immunohistochemistry of Ucp1 and DAPI on paraffin sections from ingSAT in RT 
or cold transplanted mice as in (K).  
(Q) Resting energy expenditure (REE) in RT or cold transplanted mice, measured 
between day 3 and day 21 after bacterial colonization (n=6 per group). 
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Scale in (K), (L) and (N): 100µm.  
 
Figure 4. Cold Microbiota Prevents Hypothermia 
(A, B) Rectal temperature (A), or temperature change (B), of RT or cold transplanted 
mice before, or after 4 hr of cold exposure (n=8 per group). 
(C) Infrared images of representative RT or cold transplanted mice after 4 hr cold 
exposure.  
(D–F) Infrared temperature readings from eye (D), ventral (E), or dorsal (F) region of 
mice as in (C) before, or after 4 hr cold exposure.  
(G–I) Infrared temperature readings from eye (G), ventral (H), or dorsal (I) region of 
mice as in (C) before, or after 12 hr cold exposure.  
 
Figure 5: Cold Exposed, and Cold Microbiota Transplanted Mice Show Increased 
Intestinal Length and Caloric Uptake 
(A, B). Oral glucose tolerance test (OGTT) of cold exposed mice with or without Abx 
treatment (A); or RT and cold microbiota transplanted mice 16 days after transplantation 
(B) (n=8 per group). 
(C, D) Plasma triglycerides (C) and free fatty acids (D) during oral fat tolerance test in 
RT or cold microbiota transplanted mice as in (B) (n=6 per group). 
(E, F) Total caloric uptake during 24hrs of cold or RT exposed (E), or transplanted (F) 
mice (n=8 per group). Mice were kept 2 per cage. Each cage was considered as one 
pooled sample (n=4). Data in E and F show mean±sem. 
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(G, H) Small intestine and colon lengths of cold exposed mice with or without Abx 
treatment (n=8 per group) (G); or cold exposed and RT kept GF mice(n=6 per group) 
(H).   
(I) Representative images of cecum, small and large intestine of mice as in (E–H). 
(J) Small intestine and colon lengths of 30 days cold exposed or RT kept donor mice used 
for microbiota-transplantation, 23 days after start of cohabitation at RT(n=6 per group).  
(K) Stomach, small intestine, cecum and colon weights of donor mice as in (J).  
(L) Small intestine and colon lengths of RT or cold microbiota transplanted mice as in 
(B) (n=8 per group), 21 days after transplantation, and GF controls (n=4).  
(M) Representative images of cecum, small and large intestine of mice as in (L). 
(N–P) H&E staining of duodenum of cold exposed mice with or without Abx treatment 
(N), and morphometric quantifications of duodenal perimeter (O) and villi length (P) 
(n=8 per group in triplicates, data show mean±sem). 
See also Figure S5 and S6. 
 
Figure 6: Presence and Composition of Microbiota Determines Length of Microvilli 
on Brush Border of Small Intestine 
 (A, D) Electron micrographs of jejunal enterocyte microvilli of cold exposed mice with 
or without Abx treatment (A); or GF, RT and cold microbiota transplanted mice 19 days 
after transplantation (D). Scale: 2µm. 
(B, E) Morphometric quantification of microvilli length distribution in (B) as in (A); and 
(E) as in (D).  
(C, F) Average microvilli lengths of mice as in (A, and D respectively). 
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(G) Principal component analysis (PCoA) of gene expression data in proximal jejunum of 
mice as in (A).  
(H) Top commonly regulated pathways (MetaCore pathway enrichment) in RT, RT+Abx, 
Cold and Cold+Abx differential gene expression comparisons. Legend: 1. Immune 
response: TNF-R2 signaling; 2. Main growth factor signaling cascades; 3. IGF family 
signaling in colorectal cancer; 4. c-Kit ligand signaling during hemopoiesis; 5. Apoptosis 
and survival; 6. GM-CSF signaling; 7. TGF, WNT and cytoskeletal remodelling; 8. 
Signal transduction: AKT signalling; 9. Cell adhesion: Chemokines and adhesion; 10. IL-
15 signaling via JAK-STAT cascade. 
(I, M) Relative mRNA expression in proximal jejunum of mice as in (A); or GF, or RT 
and cold microbiota transplanted GF (M), quantified by real-time PCR and normalized to 
the average expression of the house keeping Rplp0 (36b4) and Rsp16 (GF are n=4; rest 
are n=8 per group). 
(J, K) Terminal deoxynucleotidyl transferase (dUTP) nick end labeling (TUNEL) assay 
for apoptotic cells double labeled with DAPI of proximal jejunum paraffin sections of 
mice as in (A), or in (D). Scale: 200µm.   
(L) Semi-fine 1µm tick EM sections of proximal jejunum stained with toluidine blue 
displaying apoptotic cells in dark blue (marked with arrowheads) of mice as in (D). 
Round are Goblet cells. Scale: 20µm.  
(N, O) Western blotting of lysates from proximal jejunum of mice as in (D) and (A), and 
respective quantifications (O) normalized to loading controls.  
See also Figure S6. 
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Figure 7. Cold Microbiota Increases Intestinal Absorption Due to Absence of A. 
muciniphila 
(A–C) Ex-vivo measurements of glucose transport in jejunal segments excised from RT, 
cold and cold+A.muciniphila transplanted mice (n=5 per group) - with mucosal to serosal 
glucose permeability (A); radioactive glucose tracer in tissue (B); and in the lumen (C), 
of jejunum segment after 1h of transport.  
(D) Intestinal transit time of RT, cold and cold + A. muciniphila transplanted mice as in 
(A) (n=6 per group). 
(E) Intestinal length in mice transplanted with RT (n=9), cold (n=10) and cold+ 
A.muciniphila (n=6) microbiota 6 weeks after transplantation.  
(F) OGTT in cold (n=10) and cold + A .muciniphila (n=6) transplanted male mice as in 
(A). 
(G) Body weight change compared to day 0 of 7 weeks old mice, exposed to cold for 7 
days and gavaged daily with fresh A.muciniphila or vehicle (PBS) (n=5 per group). 
(H) Intestinal length of mice as in (G). 
(I) Electron micrographs of jejunal enterocyte microvilli of mice as in (G) Scale: 2µm. 
(J) Morphometric quantification of microvilli length distribution of the EM images as 
shown in (I) (n=5 per group).  
(K) OGTT of mice as in (G) 6 days after start of treatment. 
(L, M) Ex-vivo measurements of glucose transport in jejunal segments excised from mice 
as in (G) (n=5 per group) - with mucosal to serosal glucose permeability (L); radioactive 
glucose tracer in tissue after 1h of transport (M). 
 27 
(N) TUNEL assay for apoptotic cells double labeled with DAPI of proximal jejunum 
paraffin sections of mice as in (G). Bar: 200µm.   
(O) Semi-fine 1µm tick EM sections of proximal jejunum stained with toluidine blue 
showing apoptotic cells in dark blue (marked with arrowheads). Round are Goblet cells. 
Bar: 20µm.  
 (P, Q) Relative mRNA expression in proximal jejunum of mice as in (G) or (A) ((P), or 
(Q) respectively), quantified by real-time PCR and normalized to the average expression 
of the house keeping Rplp0 (36b4) and Rsp16. 
See also Figure S7. 
 
Experimental Procedures 
Animals. All C57Bl/6J (wild-type (wt)) mice (Charles River, France) were kept in a 
specific pathogen free facility (SPF) in 12 hr day/night cycles, unless otherwise specified. 
Germ-free (GF) mice were on C57Bl/6 background from the germ-free facility of the 
University of Bern, and were kept in sterile conditions until sacrifice, unless otherwise 
stated. All mice were kept 2 per cage. Fresh antibiotics were administered in the drinking 
water and changed once a week as described (Grivennikov et al., 2012), containing 
100µg/ml Neomycin, 50µg/ml Streptomycin, 100U/ml Penicillin, 50µg/ml Vancomycine, 
100µg/ml Metronidazole, 1mg/ml Bacitracin, 125µg/ml Ciprofloxacin, 100µg/ml 
Ceftazidime and 170µg/ml Gentamycin (Sigma, Germany; Alkaloid, Macedonia). Cold 
exposures were done at 6°C in a light and humidity controlled climatic chamber (TSE, 
Germany) in SPF conditions using individually ventilated cages. Acclimatized animals 
were allocated to groups based on their body weights and blood glucose levels to ensure 
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equal starting points. Microbiota transplantations were done by co-housing GF mice with 
cold exposed donors at RT for 10 days. Mice were treated with A. muciniphila by oral 
gavage at a dose 2x108 cells/0.2ml suspended in sterile anaerobic PBS as previously 
described (Everard et al., 2013). All experiments were started in 7-8 weeks old mice and 
male unless otherwise specified. All animal experiments were approved by the Swiss 
federal and Geneva cantonal authorities for animal experimentation.  
 
Statistical Analysis. Unless otherwise specified in the figure legends, significance was 
calculated using non-paired two-tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: 
p≤0.001, Brackets [ ] show comparisons of all pairs in the dataset. All values show mean 
± sd. All experiments were done at least three times, and the representative experiment is 
shown. Sample sizes and animal numbers were chosen based on power calculations of 
0.8. 
 
Accession Numbers. NCBI GEO accession number for all the sequencing data is 
GSE74228. 
 
Supplemental Information. Includes Supplemental Experimental Procedures, seven 
figures and three tables.  
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Supplemental Experimental Procedures, Supplemental Tables, and Supplemental 
References 
1) Supplemental Experimental Procedures 
 
Animals. All C57Bl/6J (wild-type (wt)) mice (Charles River, France) were kept in a 
specific pathogen free facility (SPF) in 12 hr day/night cycles in individually ventilated 
cages (IVC), unless specified otherwise for the GF or the conventional zone. All mice 
were kept 2 per cage. All experiments were started on 7-8 weeks old mice. Acclimatized 
animals were allocated to experimental groups based on their body weights and blood 
glucose levels to ensure equal starting points. For depletion of microbiota, fresh 
antibiotics were administered once a week in the drinking water as described previously 
(Grivennikov et al., 2012), containing 100µg/ml Neomycin, 50µg/ml Streptomycin, 
100U/ml Penicillin, 50µg/ml Vancomycine, 100µg/ml Metronidazole, 1mg/ml 
Bacitracin, 125µg/ml Ciprofloxacin, 100µg/ml Ceftazidime, and 170µg/ml Gentamycin 
(Sigma, Germany; Alkaloid, Macedonia). Microbiota depletion was confirmed by plating 
feces on 5% sheep blood agar plates on anaerobic and aerobic conditions; and by qPCR. 
For the conventional zone, open cages covered with filter lids were used. Cold exposures 
were performed at 6°C in a light and humidity controlled (40%) climatic chamber (TSE, 
Germany) for the SPF conditions, or in MEDI1300 from Froilabo for the conventional 
facility. Germ-free (GF) mice were on C57Bl/6 background maintained germ-free in 
flexible film axenic isolators at the Genaxen Clean Mouse of the University of Bern, and 
were kept in sterile conditions until sacrifice, unless otherwise stated. Microbiota 
transplantations were done by co-housing GF mice with 4 weeks cold exposed or RT 
donors at room temperature for 10 days. A. muciniphila (ATTC BAA-835) was grown 
anaerobically at 37°C in Schaedler Broth+VitK3 (Biomerieux). Growth and viability of 
the cells were confirmed by gram staining, qPCR and electron microscopy that showed 
the same morphology as described previously (Derrien et al., 2008). Freshly grown A. 
muciniphila culture, resuspended in sterile anaerobic PBS was given to mice by oral 
gavage at a dose of 2x108 cells in 0.2 ml of suspension, as previously described (Everard 
et al., 2013). For A. muciniphila resupply in cold exposed mice, gavage was performed 
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daily, and for GF mice A. muciniphila was monocolonized once. Repopulation was 
confirmed by qPCR using primers given in Table S3, after bacterial DNA extraction from 
fresh feces sample collected 24h after gavage (Quiagen Fast-DNA stool kit). All animal 
experiments were approved by the Swiss federal and Geneva cantonal authorities for 
animal experimentation. 
 
Gut Microbiota Profiling. Fresh feces and cecum samples were collected, immediately 
frozen and stored. Bacterial DNA content was extracted using QIAamp Fast DNA stool 
Mini Kit (Qiagen). Bacterial DNA was PCR amplified with barcoded universal bacterial 
primers targeting variable regionV4 of 16SrRNA gene. Samples were pooled and 
sequenced with Ilumina MiSeq platform. Using QIIME and custom scripts, sequences 
were quality filtered and demultiplexed using exact matches to the supplied DNA 
barcodes. Resulting sequences were then searched against the Greengenes reference 
database of 16S rRNA gene sequences, clustered at 97% by uclust. The longest sequence 
from each Operation Taxonomic Unit (OTU) thus formed was then considered as the 
OTU representative sequence, and assigned taxonomic classification via Mothur's 
Bayesian classifier, trained against the Greengenes database clustered at 98%. 
The bar chart in Figure 1H, representing phyla abundance displays the 8 phyla with the 
greatest number of sequences found by summing the number of reads from the OTUs 
within the phyla; the rest are summed in “other”. Each graph in Figure 1I and J, 
representing phyla richness represents the sum of number of detected OTUs in the 
phylum relative to the total number of OTUs detected. 
 
Metabolic Experiments. Body temperature was read with infrared camera FLIR E60 
(FLIR, UK) from 40cm distance perpendicular to the region of interest (eye, dorsal or 
ventral region) and the data was analyzed by FLIR Tools+ software. We confirmed the 
consistency with the results by rectal body temperature measurements.  Glucose tolerance 
test were performed after 12h overnight fasting by intraperitoneal injection or oral gavage 
of glucose bolus (2g/kg BW). Insulin tolerance test was performed after 6h daytime fast, 
0.75U/kg (Sigma Aldrich I9278). All mice were sacrificed after 5h fasting. 500µl of 
blood was taken from terminally anesthetized mice in tubes with 15ul of 0.5 mM EDTA, 
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4 µl of aprotinin (1.3%) and 4 µl of DPP-IV (10mM) and plasma stored at -80 °C. 
Triglycerides were measured by Trig/GB kit (Roche), free fatty by NEFA-HR kit 
(Wako). 
 
Metabolomic Analysis. Metabolites were extracted from plasma, cecum and feces as 
previously described (Fiehn and Kind, 2007). Briefly, 400µl for 30µl of plasma and 20x 
w/vol for feces and cecum of degassed chilled acetone:isopropanol (2:1 ratio) was added, 
vortexed, shaken 5min at cold, then centrifuged to pellet cell debris and protein. 
Metabolites were analyzed by gas flow injection – time of flight mass spectrometry 
(Fuhrer et al., 2011). 
 
Hyperinsulinemic-euglycemic Clamp. Hyperinsulinemic-euglycemic clamps were 
performed in conscious unrestrained catheterized mice. Seven days prior to the 
experiment, mice were anesthetized using isoflurane and a silastic catheter (0.012 inch 
inner diameter) was surgically implanted in the right jugular vein and exteriorized above 
the neck using vascular access button (Instech Laboratories Inc., Plymouth Meeting, PA). 
Euglycemic hyperinsulinemic clamps were thus performed in conscious unrestrained 
catheterized mice. Mice were fasted 5 hr before the start of the experiment (t = 0 min). At 
t = -120 min, an infusion of [3-3H] glucose (0.05 µCi/min) (Perkin Elmer, Walthman, 
MA, USA) was initiated. After 120 min, blood samples were collected from the tail vein 
to measure basal blood glucose and plasma insulin as well as to calculate the rate of 
endogenous glucose appearance (EndoRa) and glucose disposal (Rd) at basal state. At t = 
0 min, a continuous insulin infusion (4 mIU/kg body weight/min.) (NovoRapid, Novo 
Nordisk Pharma, Zurich, Switzerland) was used to induce hyperinsulinemia. The infusion 
of [3-3H] glucose was increased to 0.1 µCi/min and 50% glucose was infused to maintain 
target euglycemia (120 mg/dL) (glucose infusion rate, GIR). At steady state, in vivo 
insulin-stimulated glucose uptake in tissues was determined by a 10 µCi bolus injection 
of 2-[14C] deoxyglucose (2[14C]DG) (Perkin Elmer). After 30 min, mice were rapidly 
killed by cervical dislocation and tissues removed and stored at -80°C until use.  [3-3H] 
glucose and 2[14C]DG specific activities were determined in deproteinized blood 
samples. Plasma insulin was measured by ELISA (Mercodia, Uppsala, Sweden). EndoRa 
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under insulin stimulated state was determined by subtracting steady state GIR from Rd. 
Measurements of 2-[14C] deoxyglucose-6-phosphate concentration allowed calculation of 
the glucose utilization index of individual tissues. These experiments were performed at 
the Hyperinsulinemic-euglycemic clamp facility of the CMU Geneva, University of 
Geneva. 
 
Glucose Uptake Under Glucose Stimulated Condition. Glucose uptake in tissues 
during GTT was measured after intra-peritoneal injection of 2g/kg of D-glucose spiked 
with 2-[14C] deoxyglucose. After 45 min, mice were sacrificed and tissues rapidly 
harvested for radioactivity measurement. 
 
Positron Emission Tomography–Computed Tomography (MicroPET-CT). Mice 
were anesthetized with 2% isoflurane and were injected i.v. with 5-6 MBq of 2-deoxy-2-
[18F]fluoro-D-glucose ([18F]FDG). Two minutes after injection, mice were PET-scanned 
for 45 min then subjected to CT in a Triumph microPET/SPECT/CT system (Trifoil, 
Chatsworth, CA, USA). CT images were obtained at 80 kVp, 160 µA, and 1024 
projections were acquired during the 360° rotation with a field of view of 53.1 mm (2.3 × 
magnification). PET scans were reconstructed as 5 min frames with the built-in LabPET 
software using an OSEM3D (20 iterations) algorithm and images were calibrated in 
Bq/mL by scanning a phantom cylinder. The Triumph XO software, which uses a back-
projection engine, was used to reconstruct the CT scans with a matrix of 512 and a voxel 
size of 0.105 mm. CT scans were co-registered with the PET scans using the plugin Vivid 
(Trifoil) for Amira (FEI, Hillsboro, OR, USA) and exported as dicom files. The software 
Osirix (Pixmeo, Bernex, Switzerland) was used to quantitatively analyse the datasets and 
generate pictures. Regions of interest (ROI) were drawn on contiguous slices on CT scans 
and computed as 3D volumes for the measurements of volumes and densities of indicated 
adipose tissues. Then, PET series were converted to display Standardised Uptake Values 
(SUV) adjusted to the body weight of the animals and merged with CT sets. 3D ROIs 
derived from CT scans were used to quantify the uptake of [18F]FDG in the indicated 
adipose tissues.  
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Intestinal Loop. Mucosal to serosal glucose transport was measured as described 
(Ducroc et al., 2005). Briefly, 30 mM D-glucose spiked with 0.1 µCi/ml D [14C]-glucose 
(specific activity 55 mCi/mmol) was filled into 2 cm long proximal to mid jejunum 
segment, ligated at both sides and incubated in KRB buffer at 37°C gassed with 
Carbogen. Sampling of the bath was performed up to 60 min to assess the glucose 
transport. At 60 min, intestinal loops were collected, flushed (to collect luminal glucose 
content) and homogenized (for tissue glucose content) for radioactivity measurements. 
 
RNASeq. Next Gen Sequencing of mRNA transcripts was performed on Ilumina HiSeq 
2500 platform at iGE3 facility of the Institute of Genetics and Genomics of Geneva, 
University of Geneva. RNA was isolated from proximal jejunum segments (n=3 per 
group, each replicate was a pool of samples from 2 mice), poly-A selected and libraries 
for sequencing prepared according to Ilumina TrueSeq protocol. The reads were mapped 
with the TopHat v.2 software to the UCSC mm10 reference; on new junctions and known 
junctions annotations. Biological quality control and summarization were done with 
RSeQC-2.3.3 and PicardTools1.92. The differential expression analysis was performed 
with the statistical analysis R/Bioconductor package EdgeR v. 3.4.2, for the genes 
annotated in mm10. Briefly, the counts were normalized according to the library size and 
filtered. The genes having a count above 1 count per million reads (cpm) in at least 3 
samples were kept for the analysis. The differentially expressed genes tests were done 
with a GLM (general linear model) with a negative binomial distribution. The 
differentially expressed genes p-values are corrected for multiple testing error with a 5%. 
FDR (false discovery rate). The correction used is Benjamini-Hochberg (BH). For 
comparison of individual genes (Figure 6), p-value without correction is shown. 
For pathway enrichment analysis, transcripts with log(cpm)>1 and p≤0.05 were selected 
and multiple comparisons run through MetaCore software pipeline (Thomson Reuters). 
 
TUNEL assay. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
assay for detecting DNA fragments (apoptosis) was performed on paraffin-embedded 
sections of proximal jejunum fixed with 4% PFA with Click-IT TUNEL AlexaFluor647 
kit (Invitrogen, C10247), following manufacturer’s instructions. 
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Western Blots. Proximal jejunum segments (~5 mm) were homogenized in RIPA buffer 
and cleared by centrifugation, according to standard techniques. Western blots of whole 
tissue lysates were probed with antibodies against: cleaved caspase 3 (1:1000, Cell 
Signaling #9661), b-actin (1:2000, Cell Signaling, #3700), g-tubulin (1:5000, Sigma 
Aldrich #T6557), and PCNA (1:2000, Origene #TA800875)  
 
Real Time PCR. 1-2 µg of total RNA was used for cDNA preparation with random 
hexamer primers using High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems). Steady-state mRNA expression was measured by quantitative real-time 
PCR using the LightCycler 480 SYBR Green Master I Mix (Roche) with 386 well 
LightCycler 480 II (Roche). Transcript levels were normalized to the averaged relative 
expression of both acidic ribosomal phosphoprotein 36B4 and small ribosomal protein 16 
(Rps16) or to beta-2-microglobulin (B2m) for adipose tissue, as indicated. Primer 
sequences for real-time PCRs were as previously used (Sun and Trajkovski, 2014; 
Trajkovski et al., 2012) or as given below: 
Gene Forward primer Reverse primer 
Il15 CAGAGGCCAACTGGATAGATG ACTGTCAGTGTATAAAGTGGTGTCAAT 
Bcl2l1 TGACCACCTAGAGCCTTGGA GCTGCATTGTTCCCGTAGA 
Bcl3 GAACAACAGCCTGAACATGG TCTGAGCGTTCACGTTGG 
Mcl1 GGTATTTAAGCTAGGGTCATTTGAA TGCAGCCCTGACTAAAGGTC 
Wnt2b CCGGGACCACACTGTCTTT GCTGACGAGATAGCATAGACGA 
Vegfa TTAAACGAACGTACTTGCAGATG AGAGGTCTGGTTCCCGAAA 
Actb CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA 
Thbs1 CACCTCTCCGGGTTACTGAG GCAACAGGAACAGGACACCTA 
Sgk1 GGACTACATTAATGGTGGAGAGC CTGGCTATTTCAGCTGCGTA 
Slc2a1 GGATCCCAGCAGCAAGAAG CCAGTGTTATAGCCGAACTGC 
Slc2a2  GTCAGCTATTCATCCACATTCAGT AGCCAAGGTTCCGGTGAT 
Slc2a5 AGAGCAACGATGGAGGAAAA CCAGAGCAAGGACCAATGTC 
Slc5a1 CTGGCAGGCCGAAGTATG TTCCAATGTTACTGGCAAAGAG 
B2m TTGTCTCACTGACCGGCCT TATGTTCGGCTTCCCATTCTCC 
Rps16 GGCTCATCAAGGTGAACGGA AAATCGCTCCTTGCCCAGAA 
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Caloric Uptake. Mice were housed 2 per cage, and food intake and feces production 
were measured and collected per 24 hr. The feces were dried and ground to a fine powder 
before subjecting them to an oxygen bomb calorimeter (Parr, 6100, USA) according to 
the manufacturer’s instructions. Calorie excretion was calculated by multiplying the 
produced feces with the calories content per gram of feces. Calorie uptake was calculated 
by subtracting caloric content of the feces from the caloric content in consumed food per 
24h. 
 
Energy Expenditure. Energy expenditure between day 3 and day 21 after microbiota 
transplantation was calculated as described (Ravussin et al., 2013) (Guo and Hall, 2011) 
using the following formula: 𝐸𝑛𝑒𝑟𝑔𝑦  𝑒𝑥𝑝𝑒𝑛𝑑𝑖𝑡𝑢𝑟𝑒   𝑘𝑐𝑎𝑙𝑔= 𝐸𝑛𝑒𝑟𝑔𝑦  𝑖𝑛𝑡𝑎𝑘𝑒   𝑘𝑐𝑎𝑙𝑔 − 9.4 𝑘𝑐𝑎𝑙𝑔 ∗   ∆𝑓𝑎𝑡  𝑚𝑎𝑠𝑠 + 1.8 𝑘𝑐𝑎𝑙𝑔 ∗ ∆𝑓𝑎𝑡  𝑓𝑟𝑒𝑒  𝑚𝑎𝑠𝑠 
Energy intake was calculated by multiplying the weight of the food consumed from day 3 
to 21 by the caloric content (3.64 kcal/g), assuming equal consumption by two cage 
mates. Fat mass difference was calculated from CT quantification of subcutaneous and 
visceral fat depots at day 3 and day 21. Fat-free mass difference was calculated from 
initial and end body weights minus quantified fat. 9.4 and 1.8 kcal/g are empirical values 
for energy content of fat and lean mass (Guo and Hall, 2011). 
 
Intestinal Transit Time. Mice were gavaged at 8:00 a.m. with suspension of 6% 
carmine red (Sigma) in 0.5% methylcellulose (Sigma, M0262), placed in single cages 
without access to food, then monitored every 5 min as shown previously (Menacho-
Marquez et al., 2013). Time of the appearance of red stool was recorded as a total transit 
time. 
 
Histology and Immunofluorescence. Tissues were extracted, fixed in 4% 
paraformaldehyde (Sigma), paraffin embedded, cut in 5µm thick sections and stained 
with hematoxylin-eosin (H&E) using standard techniques. Goblet cells were stained with 
Alcian blue (MERK) and counterstained with Nuclear Fast Red. Immunohistochemistry 
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were done using rabbit anti-UCP1 (Pierce PA1-24894, 1:100), goat anti-LysosymeC 
(Santa Cruz sc-27958, 1:100) and goat anti Chromogranin A (Santa Cruz sc-1488, 
1:100). Anti-rabbit Cy3 (Jackson 711165152, 1:250), anti-goat FITC (Life technologies 
A16006, 1:500) and anti-goat-HRP (Life technologies A15999, 1:500) were used as 
secondary antibodies. Probes used for in- situ hybridization targeting olfm4 were 
synthetized by in vitro transcription with an RNA labeling kit (Roche) from a PCR DNA 
template generated using the forward mmu-Olfm4_T7 (5’CCGTAATACGACT 
CACTATAGGGAACATCACCCCAGGCTACAG 3’) and the reverse mmu-
Olfm4_SP6 (5’CCGATTTAGGTGACACTATAGAAGCCAGTTGAGCTGAATCAC 
A 3’) primers from cDNA obtained from mouse jejunum RNA extract. Images were 
acquired using Mirax (Zeiss) slide scanner microscope. Intestine morphometry was 
measured with Panoramic viewer (3D Histech), Paneth, enteroendocrine, goblet and 
Lgr5+ stem cells were quantified using Definiens Developer XD2 software, and cell/lipid 
droplet size quantification was performed using MetaMorph software (V7.7.6.0, 
Molecular Devices). All light microscopy and quantifications was done at Bioimaging 
Core Facility of Faculty of Medicine, University of Geneva. 
 
Electron microscopy (EM): After sacrifice, jejunum samples were fixed by immersion 
in a 2.5% glutaraldehyde solution (Sigma), post-fixed in 2% osmium tetroxide, stained en 
block with uranyl acetate and dehydrated and embedded in Epon 812 (Fluka Chemie, 
Buchs, Switzerland). Thin sections were cut and stained with uranyl and lead citrate. 
Images were obtained using Morgagni microscope (FEI Company, Eindhoven, 
Netherlands). EM was done at EM Core Facility of Faculty of Medicine, University of 
Geneva 
 
Statistical Analysis. Unless otherwise specified in the figure legends, significance was 
calculated using non-paired two-tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: 
p≤0.001, Brackets [ ] show significance between all pairs in the dataset. All values show 
mean ± sd, unless specified. All experiments were performed at least three times, and the 
representative experiment is shown. Sample sizes and animal numbers were chosen based 
on power calculations of 0.8.   
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 2) Supplemental Tables 
 
Table S1. Relative Quantities of Short-Chain Fatty Acids (SCFA) in Plasma and 
Cecum  
SCFA levels in plasma and cecum samples of RT or cold exposed mice with or without 
Abx for 30 days after 5 hr fasting (n=8 per group).  
a Ion intensities (arbitrary values) 
b p-values rounded to 4 decimal places, significant (p≤0.05) differences are in bold 
  
 
  
Metabolite a RT RT+Abx Cold (6°C) Cold+Abx t-test (p-values) b 
RT vs 
RT+Abx 
6C vs 
6C+Abx 
RT vs 
Cold Mean SD Mean SD Mean SD Mean SD 
PLASMA 
Acetone 14252 1237 11067 1764 13403 1691 11182 1212 0.0009 0.0129 0.2709 
Acetate 51076 4882 40687 4701 51591 4706 43369 4115 0.0007 0.0034 0.8330 
Pyruvate 67462 8127 70993 9250 65093 6840 63809 6256 0.4308 0.7121 0.5385 
Propionate 12351 823 12108 1540 13391 476 12962 1077 0.7001 0.3251 0.0080 
Butyrate 7856 838 7949 535 8743 1196 8043 286 0.7963 0.1563 0.1078 
Lactate 2926356 919692 2487622 491913 1694495 237921 1753791 546391 0.2539 0.7844 0.0025 
Acetoacetate 42948 3099 37632 2523 43429 5046 38206 4676 0.0021 0.0591 0.8218 
Hydroxybutyrate 70857 19156 61196 11542 137505 59524 119296 36631 0.2420 0.4964 0.0093 
Fumarate 9697 2156 13582 5817 15033 6709 13055 6712 0.0983 0.5787 0.0503 
Succinate 8781 1624 9808 4022 10286 1559 10303 1822 0.5142 0.9847 0.0796 
CECUM 
Acetone 10041 1465 13724 1653 8930 1693 14146 700 0.0003 0.0000 0.1823 
Acetate 22216 2938 32557 4090 22414 3268 36280 1554 0.0000 0.0000 0.9003 
Pyruvate 44706 3627 85363 15937 44777 5026 90872 6047 0.0000 0.0000 0.9749 
Propionate 12690 1213 19684 3453 11129 1250 22704 944 0.0001 0.0000 0.0238 
Butyrate 239212 79243 4770 725 262692 101515 5300 775 0.0000 0.0000 0.6141 
Lactate 309546 129673 226861 108164 185599 109860 192868 56932 0.1877 0.8776 0.0582 
Acetoacetate 28412 1885 84358 24715 33685 7384 95822 5117 0.0000 0.0000 0.0706 
Hydroxybutyrate 11611 4305 9278 1839 13062 4436 12048 1286 0.1806 0.5708 0.5174 
Fumarate 8083 2486 6192 1303 7340 3616 5551 788 0.0775 0.2240 0.6396 
Succinate 95436 24099 28043 20962 91668 19589 18227 3484 0.0000 0.0000 0.7366 
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Metabolite a Germ-free 
RT 
transplanted 
Cold 
transplanted 
t-test (p-values) b 
GF:RT 
trans 
GF:Cold 
trans 
RT tr: 
Cold tr Mean SD Mean SD Mean SD 
PLASMA  
Acetone 8017 1311 8332 751 8840 877 0.6184 0.2198 0.2534 
Acetate 32939 5154 34811 2843 35186 3888 0.4490 0.4143 0.8369 
Pyruvate 49582 6188 44995 4108 49911 3743 0.1695 0.9096 0.0306 
Propionate 11781 1095 12128 1067 12059 581 0.6194 0.5697 0.8764 
Butyrate 7033 324 6871 490 6876 243 0.5725 0.3641 0.9796 
Lactate 1022758 333852 980672 271659 1192952 213612 0.8244 0.3026 0.1141 
Acetoacetate 26023 2083 24255 693 25660 2216 0.0629 0.7913 0.1327 
Hydroxybutyrate 26171 3756 55827 42990 59993 37190 0.2114 0.1069 0.8435 
Fumarate 8038 915 7875 690 7980 771 0.7442 0.9102 0.7869 
Succinate 9327 1186 8886 923 10224 1458 0.5073 0.3138 0.0573 
CECUM 
 Acetone 12381 547 5216 706 5312 892 0.0000 0.0000 0.7474 
Acetate 36729 3730 19655 2369 21573 3439 0.0000 0.0000 0.0906 
Pyruvate 118652 9047 39654 3659 40517 4020 0.0000 0.0000 0.5457 
Propionate 15359 2005 11490 1082 13406 1899 0.0000 0.0468 0.0025 
Butyrate 43678 58858 256218 62775 346505 150430 0.0000 0.0001 0.0460 
Lactate 2719683 492114 64981 20877 85786 21845 0.0000 0.0000 0.0129 
Acetoacetate 91450 8186 24569 2876 26767 4785 0.0000 0.0000 0.1458 
Hydroxybutyrate 76792 18202 4849 1391 5874 2031 0.0000 0.0000 0.1232 
Fumarate 5414 582 4998 4459 5251 2615 0.8251 0.8831 0.8487 
Succinate 21421 2992 88137 50114 154989 80349 0.0049 0.0007 0.0120 
 
Table S2. Relative Quantities of SCFA in Plasma and Cecum  
SCFA levels in plasma or cecum of GF (n=4), RT (n=8) or cold (n=8) transplanted mice 
(day 21) after 5 hr fasting. 
All values in Tables S1 and S2 show mean ± sd. Significance was calculated using non-
paired two tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001.  
a Ion intensities (arbitrary values) 
b p-values rounded to 4 decimal places, significant (p≤0.05) differences are in bold 
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Table S3. Primer Sequences Used for Gut Microbiota Profiling by qPCR  
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Hermann-Bank et al., 2013; 
Muhling et al., 2008; Schwieger 
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Hermann-Bank et al., 2013; 
Muhling et al., 2008) 
 
Reverse ACACYTAGYACTCATCGTTT 
Phylum 
Bacteroidetes   
16S region 
Forward CCGGAWTYATTGGGTTTAAAGGG (Hermann-Bank et al., 2013; 
Muhling et al., 2008) Reverse GGTAAGGTTCCTCGCGTA 
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Forward CAGCACGTGAAGGTGGGGAC 
(Everard et al., 2013) 
Reverse CCTTGCGGTTGGCTTCAGAT 
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Supplemental Figure Legends 
 
Figure S1: Body Weight and Temperature After Cold Exposure and Antibiotics 
(Abx) Treatment, Related to Figure 1  
(A, B) Body weight gain (A), and food consumption (B) of cold exposed mice and RT 
controls over 36 days.  
(C, D) Weight of ingSAT (C), and pgVAT (D) of cold exposed mice and RT controls for 
10 (n=4 per group), or 31 days. 
(E) Ratios of cold vs. RT fat amount at days 10 and 31 shown as % of mice as in (C, D) 
(F) Resting energy expenditure (REE) in RT or cold exposed mice, measured between 
day 0 and day 31 after cold exposure, shown per day. 
(G) Calorimetric measurements of 24hr fecal caloric content of Abx or control mice (n=8 
per group). Mice were kept 2 per cage. Each cage was considered as one pooled sample 
(n=4).  
(H-J) Body weight (H), changes in body weight relative to start value (I) and blood 
glucose levels (J) of mice with or without access to food exposed to cold for 4 and 8 hr 
(see Figure 1A for associated body temperature).  
(K-N) Rectal body temperature of Abx and control mice after 3, 6 and 12 hr of acute cold 
exposure, performed at week 1 (K), week 2 (L), weeks 3 (M), and week 4 (N) after the 
start of the Abx treatment. 
(O-R) Blood glucose of mice as in (K-N, respectively) performed at week 1 (O), week 2 
(P), weeks 3 (Q), and week 4 (R) after the start of the Abx treatment. 
(S, T) Food intake (S), and water consumption (T) during cold exposure of mice as in (K-
N). The shown amount is for the total period of cold exposure.  
All panels show mean ± sd, except K-R, which show mean ± sem. Unless otherwise 
stated, in all panels n=8 per group. Significance was calculated using non-paired two-
tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001. 
 
Supplemental Figure Legends
Figure S2. Cold Exposure Induces Major Reshaping of the Gut Microbiota, Related 
to Figure 1 
(A-B) PCoA based on Weighted UniFrac analysis on operational taxonomic units 
(OTUs). Each symbol represents a single sample of cecum content of 31 days cold 
exposed mice (n=5) and their RT controls (A) (n=4); and of feces after 0, 11 and 31 days 
of cold exposure (B) (n=6-7 per group).  
(C, E) Phylum level proportional abundance as described in the barchart of Figure 1G in 
(C) feces (n=7+8) and (E) cecum (n=4+5).  
(D, F) Hierarchical clustering diagram constructed using the average-neighbor (HC-AN) 
method comparing (D) cecum content (n=4-5 per group) and (F) feces sample (n=7-8 per 
group) of 31 days cold or RT exposed mice. The heat map shows the relative abundance 
of the top 100 OTUs displaying the most significant p-value after a Welch t-test 
comparison of the two groups. The assigned OTUs are presented as the following: 
Phylum, Class, Order, Family, Genus, and Specie. R: RT; C: Cold exposed; with suffix c: 
cecum; without suffix: feces. 
All values show mean ± sd. Significance was calculated using non-paired two-tailed 
Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001. 
 
Figure S3. Cold Exposure Alters the Gut Microbiota and Abolishes A. muciniphila, 
Related to Figure 1   
(A, B) Hierarchical clustering diagram constructed using the average-neighbor (HC-AN) 
method comparing cecum (n=4-5 per group) and feces (n=6-7) of 31-day cold or RT 
exposed mice. In (A) associated heat map shows the relative abundance of the top 100 
OTUs displaying the most significant p-value after a Welch t-test comparison of the two 
groups. In (B) associated heat map shows the relative abundance of representative OTUs 
selected for a chosen p-value threshold (p < 0.05), obtained with a Welch t-test 
comparison of the two groups, and then grouped into families. One representative OTU 
with the greatest difference between the two group means from each family is selected 
for inclusion in the heat map diagram.  R: RT; C: Cold exposed; with suffix c: cecum; 
without suffix: feces. 
(C, D) Bacterial diversity assessed by Shannon diversity index of feces (C) collected after 
0, 11 or 31 days of cold exposure and their RT controls and cecum content (D) of 31-day 
cold or RT exposed mice (n=4-5 per group).  
(E, F) Akkermansia muciniphila species abundance in feces (E) (n=6+8), and cecum 
content (F) (n=4+5) of 31-day cold or RT exposed mice assessed by 16S sequencing.  
(G, H) Profiles of the top 9 OTUs generating the lowest p-value after ANOVA analysis 
when comparing (G) cecum content (n=4+5) and (H) feces (n=6+8) of 31-day cold 
exposed and RT control mice. The y-axis represents the OTU abundance. 
(I, J) Relative abundance of Firmicutes (I) and Bacteroidetes (J) phylum in 31-day cold 
exposed mice and RT controls kept in conventional animal facility, quantified by qPCR 
and normalized to bacteria universal 16SrRNA (V4-V5 region) (n=8 per group).  
(K, L) Relative abundance of Firmicutes (K) and Bacteroidetes (L) phylum in mice 
transplanted with RT or cold microbiota at day 19 after colonization (n=6-7 per group); 
and their donors kept in SPF conditions at the day of colonization (n=6 per group), 
quantified by qPCR and normalized to bacteria universal 16SrRNA (V4-V5 region). 
Unless otherwise stated, all values show mean ± sd. Significance was calculated using 
non-paired two-tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001. 
 
Figure S4. Increased Glucose Peak During OGTT and Increased Insulin Sensitivity 
of Cold Exposed Mice With or Without Microbiota Depletion, Related to Figure 2, 
Figure 3 and Figure 5 
(A) Steady-state glucose infusion rate (GIR) in RT and cold-exposed mice during 
euglycemic-hyperinsulinemic clamp (n=6). 
(B) Coronal view of the CT scans of cold or RT transplanted mice 21 days after 
transplantation.  
(C-G) Normalized (C, E, G), or absolute (D, F) glucose levels during OGTT of RT or 
cold exposed male mice with or without Abx at day 23 (C) and day 7 (D, E); or female 
mice at day 16 (F, G) (n=4 per group). 
(H, I) Insulin tolerance test (ITT) at day 8 (H) and intra-peritoneal glucose tolerance test 
(IPGTT) at day 17 (I) of RT or cold exposed male mice with or without Abx (n=8 per 
group). 
(J) Insulin levels during OGTT as in Figure 5B of RT or cold transplanted mice (n=6 per 
group). 
All values show mean ± sd. Significance was calculated using non-paired two-tailed 
Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001 
 
Figure S5. Cold Exposure and Abx Treatment Increase Small Intestinal Length and 
Weight, Related to Figure 5 
(A) Images of representative RT or cold exposed male mice with or without antibiotics 
during dissection at day 31. 
(B, C) Small intestine length (B) and weight (C) of RT or cold exposed mice with or 
without antibiotics (day 9) (n=4 per group). 
(D) Weights of different organs of gastrointestinal tract of mice as in (A) (n=8 per group). 
(E-G) Weights of different organs of gastrointestinal tract (E), Fat pads (F), or other 
organs (G) collected from of RT or cold exposed GF mice (n=6 per group). 
(H) Weights of different organs of gastrointestinal tract of GF, RT or cold transplanted 
mice at day 21 after transplantation (GF n=4, RT and Cold transplanted n=8 per group). 
All values show mean ± sd. Significance was calculated using non-paired two-tailed 
Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001. 
 
Figure S6. Changes in the Intestinal Cell Composition, Related to Figure 6 
(A) Immunofluorescence of chromogranin A in ileum sections of RT or cold exposed 
mice with or without antibiotics (day 31). 
(B, C) Total number of chromogranin A positive cells per section (B) or relative 
proportion of chromogranin A positive cells per tissue surface (C) of sections as in (A) 
(n=5 per group). 
(D) Immunofluorescence of chromogranin A in duodenum sections of RT or cold 
microbiota transplanted female mice (day 19 post transplantation). 
(E) Relative proportion of chromogranin A positive cells per tissue surface (C) of 
sections as in (D) (n=5 per group). 
(F) Alcian blue staining (for goblet cells) of duodenum sections of RT or cold exposed 
mice with or without Abx (day 31). 
(G, H) Total number of goblet cells per section (G) and relative proportion of goblet cells 
normalized to perimeter (H) of sections as in (F) (n=6 per group). 
(I) In situ hybridization for Olfm4 of duodenum sections of RT or cold exposed mice 
with or without antibiotics (day 31). 
(J, K) Quantification of total number of Olfm4+ cells per section (J) and relative 
proportion of Olfm4+ cells normalized to perimeter (K) of sections as in (I) (n=6 per 
group). 
(L) Alcian blue staining for goblet cells of duodenum sections of RT or cold microbiota 
transplanted female mice (Day 19 post transplantation).  
(M) Total number of goblet cells per section of duodenum as in (L) (n=6 per group). 
(N) Heatmap of log2 fold change of gene expression from most significantly regulated 
patways of mice as in (A), compared to RT=1. Each value represents pooled sample from 
two mice. 
All values show mean ± sd. Significance was calculated using non-paired two-tailed 
Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001. 
 
Figure S7. A. muciniphila Supplementation Over Cold Microbiota Reduces 
Intestinal Length But Does Not Affect the Browning, Related to Figure 7 
(A) Representative images of cecum, small and large intestine of mice transplanted with 
cold microbiota with or without A. muciniphila co-transplantation. 
(B) Insulin levels during OGTT as in Figure 7F of mice transplanted with cold microbiota 
with or without A. muciniphila co-transplantation (n=6 per group, day 23).  
(C) Insulin tolerance test normalized to initial glycemia of mice as in (A) (n=6 per group, 
day 16). 
 (D) Relative mRNA expression in ingSAT tissues 5 weeks after transplantation of mice 
as in (A) quantified by real-time PCR and normalized to the house keeping beta-2-
microglobulin (B2m) Rplp0 (36b4) and Rsp16 (n=6 per group). 
(E-G) Infrared temperature readings of eye (E), ventral (F) or dorsal (G) temperature after 
4 hr cold exposure  (day 18).  
(H-J) Infrared temperature readings of eye (H), ventral (I) or dorsal (J) temperature after 
12 hr cold exposure  (day 18).  
(K, L) Relative abundance of Bacteroidetes (K) and Firmicutes (L) phylum in mice 
transplanted with RT or cold microbiota with or without A.muciniphila 21 days after 
transplantation, quantified by qPCR and normalized to bacterial universal 16SrRNA (V4-
V5 region). In (E-L) n=10 cold transplanted, n=6 cold co-transplanted with 
A.muciniphila. 
(M-P) (M) Bacterial abundance per g of feces (day 10), (N) intestinal length, (O) 
duodenum perimeter, and (P) distribution of microvilli lengths from EM images from GF 
mice monocolonized with A.muciniphila at 7 weeks of age and kept at RT for 12 days 
(n=4 per group).  
(Q, R) (Q) Body weight, and (R) fat pad weight of cold exposed 7 weeks old C57BL6J 
mice, exposed to cold for 7 days and gavaged daily with fresh A.muciniphila monoculture 
resuspended in anaerobic PBS or by vehicle (PBS).  
(S) Food consumption of mice as in (P). Values show the food intake of 2 mice per 24 
hrs.  
(T) Relative bacterial abundance of mice as in (Q) 7 days after the start of treatment, 
quantified by qPCR and normalized to bacteria universal 16SrRNA (V4-V5 region). 
(U) Area under the curve during the first 30 min of OGTT as in Figure 7I of mice as in 
(Q) day 6 days after the start of treatment.  
In (Q-R) n=5 per group. All values show mean ± sd. Significance was calculated using 
non-paired two tailed Student’s t-test.*: p≤0.05, **: p≤0.01, ***: p≤0.001.  
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